Top section
Top section
International Finance Corp’s drive to introduce development finance to the CLO market is advancing. Its second deal of $509m had more investors, more tranches and better pricing, supporting its rapid growth
Divisions deepen over multilateral development banks’ climate commitments
Deal rules and slow primary market make ramping up deals difficult
More articles
More articles
More articles
-
Sino Biopharmaceutical has increased its refinancing loan to $1bn after receiving a strong response during syndication. -
After the volatility that defined much of 2018, capital market bankers in Asia started the year full of trepidation. Would the Federal Reserve speed up its slow-motion rate rises? Would Chinese defaults become a major problem? Would investors extend the period of hibernation they began during the bearish end to last year?
-
Leveraged finance loans for Chinese companies will rebound this year, driven in part by the abundant liquidity available from the private equity funds. But winning government approval for deals will remain a stumbling block. Pan Yue reports
-
The year started with a few headwinds for China-focused loans bankers, including uncertainties coming from the US-China trade war, rising bond and loan defaults and reduced Taiwanese liquidity. But with huge refinancing needs and a volatile bond market, many are anticipating a promising year. Pan Yue reports.
-
Investment grade loans bankers are pinning more hope on the coming quarter after the slowest start to a year in the past five years.
-
The European leveraged finance market is heating up, as long-awaited deals for the buyouts of UK plastics company RPC and German online listings firm Scout24 break cover. The two chunky deals will deliver much needed new money supply after a sluggish start to the year.
Sub-sections
